NIP
RXST icon

Nicholas Investment Partners’s RxSight RXST Stock Holding History

Nicholas Investment Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-74,347
Closed -$3.67M – 244
2024
Q3 		$3.67M Sell
74,347
-69,424
-48% -$3.56M 0.34% 115
2024
Q2 		$8.65M Buy
143,771
+75,094
+109% +$4.29M 0.9% 30
2024
Q1 		$3.54M Buy
68,677
+12,263
+22% +$602K 0.36% 106
2023
Q4 		$2.27M Buy
+56,414
New +$1.65M 0.27% 132

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Nicholas Investment Partners's RXST Position: Q4 2024 in Review

Nicholas Investment Partners sold out of RxSight (RXST) in Q4 2024, closing a stake of 74,347 shares — an estimated $3.67M sold.

Nicholas Investment Partners first reported a position in RXST in Q4 2023 and held it in 4 quarters. The position peaked at $8.65M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Nicholas Investment Partners reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 74,347 RxSight shares in Q4 2024, an estimated $3.67M.
  • Nicholas Investment Partners first reported a position in RxSight in Q4 2023 and held it in 4 quarters.
  • Nicholas Investment Partners's RxSight position peaked at $8.65M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.